UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.74 -0.89 (-1.08%) GOLD FUTURES
2,302.80 -54.90 (-2.33%) DOW
38,024.96 -361.13 (-0.94%) Bitcoin GBP
50,119.69 -539.11 (-1.06%)
Pharming Group N.V. (PHAR)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 9.36 |
| Open | 9.91 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 9.91 - 9.91 |
| 52-week range | 9.27 - 16.71 |
| Volume | |
| Avg. volume | 2,722 |
| Market cap | 667.377M |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
Pharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Simply Wall St.
Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
Pharming Group N.V. ( AMS:PHARM ) came out with its yearly results last week, and we wanted to see how the business is...
- Simply Wall St.
Pharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)
Pharming Group ( AMS:PHARM ) Full Year 2023 Results Key Financial Results Revenue: US$245.3m (up 19% from FY 2022). Net...
© 2024 Yahoo. All rights reserved.